Where does Sangamo Biosciences, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Sangamo Biosciences, Inc. ranks #5,630 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Sangamo Biosciences, Inc. hold?

Sangamo Biosciences, Inc. holds 61 US utility patents granted between 2015 and 2024, spanning 14 technology areas.

What is Sangamo Biosciences, Inc.'s Innovation Score?

Sangamo Biosciences, Inc. has an Innovation Score of 42.3 out of 100 (top 31% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Sangamo Biosciences, Inc.'s patent grant rate increasing or decreasing?

Sangamo Biosciences, Inc.'s recent grant velocity is -98% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Sangamo Biosciences, Inc.'s patents?

Sangamo Biosciences, Inc.'s patents average 13.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Sangamo Biosciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Sangamo Biosciences, Inc.

Q: What technology areas does Sangamo Biosciences, Inc. focus on?

Sangamo Biosciences, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 61 patents, ranking #168 of 4,144 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

USPTO PatentsView assignee record - 61 granted patents across 14 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Sangamo ranks #5,630 of 49,997 tracked US assignees by granted-patent volume, with 61 patents across 14 technology areas.

#5,630
of 49,997 US assignees by volume: Top 31%
by Innovation Score (42.3/100): 13.5
avg claims per patent: -98%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5630 · US Corporation #5,630 · 61 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 61 grants
UPPER-Q #5,630/49,997
PHOTO-FINISH Raytheon Canada
CPC-FOCUS C12N · 14 areas
INNOV-PAR 42.3/100
CLAIMS-RICH 13.5 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -98% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Raytheon Canada Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Sangamo’s 42.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.3 pts (34%) Velocity 6.7 pts (16%) Breadth 13.2 pts (31%) Claim depth 8.1 pts (19%)

Qualcomm Incorporated · highest

85
Detnet South Africa… · near

42
Fractal Antenna… · near

42
Medibotics · near

42
Robert Bosch… · near

42
Sangamo Biosciences · this assignee

42
3D Lighting… · lowest

7

What this shows Sangamo's Innovation Score is 42.3/100 (top 31% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Sangamo?

Each dot is one of Sangamo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sangamo’s own 13.5 claims/patent is ABOVE the 11.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Sangamo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Sangamo's grants concentrate

Sangamo Biosciences, Inc. is a focused PatentsView assignee: 14 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2016 (29 grants) versus a trough of 1 in 2024. By volume, Sangamo sits between Raytheon Canada Limited and Tetra Technologies, Inc..

Sangamo's three-year grant acceleration

Sangamo Biosciences, Inc. shows 1 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Raytheon Canada

61
Ring Container

61
Rubbermaid Commer…

61
Samsung Heavy IND

61
Science Applicati…

61
Server Technology

61
Streetcar ORV

61
Tetra

61
Sangamo Bioscienc… ◀

61

What this shows Sangamo holds 61 patents at rank #5,628, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Sangamo

By rank, the assignees closest to #5,628 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Sangamo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Sangamo, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Sangamo ranks #168 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

Fractal Antenna Systems, Inc. 42 Robert Bosch Automotive Steering LLC 42 Detnet South Africa (PTY) Ltd 42 Medibotics LLC 42

Similar claim depth

Nearest assignees by average claims per patent (13.5 here).

Techtronic Cordless GP 13.5 avg Gulfstream Aerospace Corporation 13.5 avg Electrolux Home Products, Inc. 13.5 avg GS Yuasa International Ltd. 13.5 avg

Sangamo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 31% higher than 69% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Sangamo Biosciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	18	29.5%
2016	29	47.5%
2017	13	21.3%
2024	1	1.6%

Which technologies does Sangamo Biosciences, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 61

C07K - Peptides 48

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 29

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 28

C12Y - Enzymes 21

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

Y02A - Technologies FOR Adaptation TO Climate Change 4

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 3

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 3

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

A01H - NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques 2

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Sangamo Biosciences, Inc.'s patent record in context - here's where to go next.

Sangamo Biosciences, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #5,630 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Sangamo Biosciences, Inc. against Raytheon Canada Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.